MHR
Matthew Hamilton Rosenberg’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Hold |
1,307
| – | – | 0.04% | 241 |
|
|
2025
Q1 | $146K | Hold |
1,307
| – | – | 0.04% | 242 |
|
|
2024
Q4 | $127K | Sell |
1,307
-7
| -0.5% | -$681 | 0.03% | 269 |
|
|
2024
Q3 | $151K | Buy |
1,314
+126
| +11% | +$14.5K | 0.04% | 241 |
|
|
2024
Q2 | $127K | Sell |
1,188
-134
| -10% | -$14.3K | 0.04% | 247 |
|
|
2024
Q1 | $127K | Sell |
1,322
-1
| -0.1% | -$96 | 0.04% | 272 |
|
|
2023
Q4 | $134K | Sell |
1,323
-2
| -0.2% | -$202 | 0.04% | 245 |
|
|
2023
Q3 | $135K | Buy |
1,325
+60
| +5% | +$6.11K | 0.05% | 238 |
|
|
2023
Q2 | $128K | Buy |
1,265
+2
| +0.2% | +$202 | 0.04% | 253 |
|
|
2023
Q1 | $116K | Sell |
1,263
-213
| -14% | -$19.6K | 0.04% | 283 |
|
|
2022
Q4 | $134K | Hold |
1,476
| – | – | 0.05% | 256 |
|
|
2022
Q3 | $112K | Hold |
1,476
| – | – | 0.04% | 261 |
|
|
2022
Q2 | $125K | Buy |
1,476
+644
| +77% | +$54.5K | 0.05% | 255 |
|
|
2022
Q1 | $73K | Buy |
832
+91
| +12% | +$7.98K | 0.03% | 371 |
|
|
2021
Q4 | $65K | Sell |
741
-267
| -26% | -$23.4K | 0.02% | 374 |
|
|
2021
Q3 | $82K | Sell |
1,008
-540
| -35% | -$43.9K | 0.03% | 312 |
|
|
2021
Q2 | $141K | Buy |
1,548
+170
| +12% | +$15.5K | 0.07% | 200 |
|
|
2021
Q1 | $118K | Buy |
1,378
+260
| +23% | +$22.3K | 0.07% | 223 |
|
|
2020
Q4 | $106K | Hold |
1,118
| – | – | 0.07% | 223 |
|
|
2020
Q3 | $97K | Sell |
1,118
-26
| -2% | -$2.26K | 0.07% | 212 |
|
|
2020
Q2 | $100K | Buy |
1,144
+135
| +13% | +$11.8K | 0.08% | 191 |
|
|
2020
Q1 | $84K | Buy |
+1,009
| New | +$84K | 0.08% | 159 |
|